Funding Opportunities Specific to COVID-19
This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).
Active Funding Opportunities
Title |
Notice Number |
Organization(s) |
Release Date |
Expiration Date |
Activity Code(s) |
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) |
RFA-AI-20-078 |
NIAID,
NIEHS
|
Jan 12, 2021 |
Jun 5, 2021
|
U19
|
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) |
RFA-AI-20-077 |
NIAID,
NIEHS
|
Jan 12, 2021 |
Jun 5, 2021
|
U01
|
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases |
NOT-AR-21-012 |
NIAMS
|
Jan 5, 2021 |
Nov 19, 2021
|
R01, R21
|
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research |
NOT-MH-21-120 |
NIMH
|
Dec 23, 2020 |
Jun 2, 2023
|
333
|
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NOT-MD-21-008 |
NIMHD,
NIAID,
NIAMS,
NCI,
ORWH,
NIMH,
NINR,
OBSSR,
ODP,
NHLBI,
NIDCR,
SGMRO
|
Dec 17, 2020 |
Jan 8, 2022
|
R01
|
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs |
NOT-TR-21-011 |
NCATS
|
Dec 17, 2020 |
Jun 2, 2021
|
333
|
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) |
NOT-OD-21-020 |
NIH,
NLM,
NIEHS,
NIAMS,
NIDCR,
OBSSR,
NIGMS,
NHLBI,
NCI,
NIAAA,
NINR,
NCATS,
ORWH,
NHGRI,
FIC,
NCCIH,
NIMH,
THRO,
NIDA,
NINDS,
NEI,
NIMHD,
NIAID,
NIA,
FDA,
NIBIB,
NIDCD,
NICHD,
NIDDK
|
Nov 17, 2020 |
Mar 5, 2021
|
333
|
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects |
NOT-AI-21-002 |
NIAID
|
Nov 10, 2020 |
Jun 12, 2021
|
P01
|
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection |
NOT-DA-20-084 |
NIDA
|
Oct 27, 2020 |
Sep 8, 2024
|
R01, R03, R21
|
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-21-006 |
NCATS
|
Oct 23, 2020 |
Mar 17, 2021
|
UH2, U34, U01
|
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-21-006 |
NCATS
|
Oct 23, 2020 |
Mar 17, 2021
|
UH2, U34, U01
|
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) |
NOT-HL-20-814 |
NHLBI
|
Sep 15, 2020 |
Jul 6, 2024
|
R01
|
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 |
NOT-AI-20-065 |
NIAID
|
Aug 13, 2020 |
Sep 1, 2021
|
U01
|
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities |
NOT-MD-20-025 |
NIMHD,
NCI,
NIDA,
NLM,
ODP,
OBSSR,
NIMH,
NIAMS
|
Aug 13, 2020 |
May 8, 2023
|
R01
|
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) |
RFA-TR-20-003 |
NCATS
|
Aug 5, 2020 |
Jan 24, 2021
|
U01
|
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
PAR-20-256 |
NIAID
|
Jul 13, 2020 |
Jul 8, 2021
|
S10
|
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-059 |
NIAID
|
Jul 6, 2020 |
Jul 2, 2021
|
333
|
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) |
PAR-20-243 |
NIMH,
NCCIH,
NEI,
NIA,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIMHD,
NINR,
OBSSR,
ODP,
ORWH
|
Jun 25, 2020 |
Mar 3, 2021
|
R01
|
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project |
NOT-OD-20-129 |
NIH,
NCATS,
NCCIH,
NCI,
NHGRI,
NHLBI,
NIAID,
NIAMS,
NICHD,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIMHD,
NINDS,
ORIP
|
Jun 25, 2020 |
Jul 13, 2021
|
333
|
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) |
PAR-20-234 |
NIA
|
Jun 15, 2020 |
Feb 2, 2021
|
R01
|
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders |
NOT-DC-20-008 |
NIDCD
|
Jun 4, 2020 |
Sep 8, 2022
|
R01, R21, R41/R42, R43/R44
|
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System |
NOT-NS-20-051 |
NINDS
|
Apr 30, 2020 |
Apr 15, 2021
|
333
|
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA |
NOT-AA-20-011 |
NIAAA
|
Apr 16, 2020 |
Apr 16, 2021
|
333
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences |
NOT-OD-20-097 |
OBSSR,
NCCIH,
NCI,
NHGRI,
NHLBI,
NIAAA,
NICHD,
NIDDK,
NIEHS,
NINR,
ODP,
ORWH
|
Apr 13, 2020 |
Apr 1, 2021
|
333
|
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NOT-ES-20-020 |
NIEHS
|
Apr 10, 2020 |
May 4, 2021
|
333, R21
|
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities |
NOT-MD-20-019 |
NIMHD,
NIAAA,
NIMH,
ODP
|
Apr 9, 2020 |
May 1, 2021
|
333
|
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus |
NOT-TR-20-017 |
NCATS
|
Apr 9, 2020 |
Jan 26, 2022
|
333
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus |
NOT-MH-20-047 |
NIMH,
NIAAA,
ODP
|
Apr 9, 2020 |
Apr 16, 2021
|
333
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus |
NOT-TR-20-016 |
NCATS
|
Apr 9, 2020 |
Jan 26, 2022
|
333
|
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
NOT-ES-20-015 |
NIEHS
|
Apr 8, 2020 |
May 4, 2021
|
333, R21
|
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-AG-20-022 |
NIAAA,
NIMH
|
Apr 2, 2020 |
May 1, 2021
|
333
|
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-031 |
NIAID
|
Mar 27, 2020 |
Apr 5, 2021
|
R03, R21, 333, R01, R43/R44, R41/R42
|
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 |
NOT-GM-20-025 |
NIGMS
|
Mar 25, 2020 |
Feb 6, 2021
|
333
|
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need |
NOT-TR-20-011 |
NCATS
|
Mar 24, 2020 |
Jul 10, 2021
|
333, U01, R21, U54
|
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus |
NOT-DA-20-047 |
NIDA
|
Mar 19, 2020 |
Mar 31, 2021
|
333
|
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
PA-20-135 |
NIH,
NCATS,
NCCIH,
NCI,
NHGRI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDCD,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINR,
NLM,
ORWH,
OSC
|
Mar 10, 2020 |
Sep 8, 2025
|
333
|
Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) |
NOT-OD-20-048 |
ORWH,
NCATS,
NCCIH,
NCI,
NEI,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIAMS,
NIBIB,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NIMH,
NIMHD,
NINDS,
NINR,
NLM,
OD
|
Dec 13, 2019 |
Jan 26, 2021
|
333
|
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) |
RFA-OD-19-029 |
ORWH,
NCCIH,
NHGRI,
NHLBI,
NIA,
NIAAA,
NIAID,
NIDA,
NIDCR,
NIEHS,
NIMH,
NINR
|
Sep 27, 2019 |
Nov 27, 2021
|
R01
|
Expired Funding Opportunities
Title |
Notice Number |
Organization(s) |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts |
NOT-HG-21-020 |
NHGRI
|
Dec 10, 2020 |
Jan 16, 2021
|
333 |
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities |
NOT-MD-21-007 |
NIMHD
|
Dec 7, 2020 |
Dec 31, 2020
|
|
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) |
NOT-OD-21-035 |
NIH,
NIDCR,
NHLBI
|
Nov 25, 2020 |
Dec 5, 2020
|
333 |
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-21-002 |
NIEHS
|
Nov 17, 2020 |
Dec 30, 2020
|
333 |
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities |
NOT-ES-21-002 |
NIEHS
|
Nov 17, 2020 |
Dec 30, 2020
|
333 |
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with
Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) |
RFA-OD-20-023 |
NIH,
FIC,
NCATS,
NHLBI,
NIAID,
NIAMS,
NICHD,
NIDA,
NIMHD
|
Aug 6, 2020 |
Oct 1, 2020
|
R61/R33 |
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) |
RFA-OD-20-022 |
NIH,
NIA,
NIDCD,
ORWH,
NICHD,
NLM,
NINR,
NINDS,
NIDCR
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) |
RFA-OD-20-021 |
NIH,
NIAAA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
R42 |
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) |
RFA-OD-20-020 |
NIH,
NIAAA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
R44 |
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) |
RFA-OD-20-019 |
NIH,
NIAAA,
NIA,
NCCIH,
NIDCD,
NIDDK,
NIEHS,
NIGMS,
NICHD,
NIMHD,
NLM,
NINR,
NCATS,
OBSSR,
NHLBI,
NIDCR,
NIDA
|
Aug 6, 2020 |
Oct 1, 2020
|
U24 |
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) |
RFA-OD-20-018 |
NIH,
NIA,
NCI,
RM,
NCATS,
NHLBI,
NIDCR,
NIDA,
NHGRI
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) |
RFA-OD-20-018 |
NIH,
NIA,
NCI,
RM,
NCATS,
NHLBI,
NIDCR,
NIDA,
NHGRI
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) |
RFA-OD-20-017 |
NIH,
NIAAA,
NIA,
NIAMS,
NICHD,
NIBIB,
NIMHD,
NLM,
NCATS,
NHLBI,
NIDCR
|
Aug 6, 2020 |
Sep 19, 2020
|
U18 |
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) |
RFA-OD-20-016 |
NIH,
NIAAA,
NIDDK,
NIGMS,
NIMHD,
NLM,
NINR,
OBSSR,
NIDCR,
NIDA
|
Aug 6, 2020 |
Oct 1, 2020
|
R01 |
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) |
RFA-OD-20-015 |
NIH,
NIEHS,
NIGMS,
NLM,
NIDA
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) |
RFA-OD-20-014 |
NIH,
NIAAA,
NIA,
NCCIH,
NCI,
NICHD
|
Aug 6, 2020 |
Sep 16, 2020
|
U01 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool |
NOT-OD-20-152 |
NIH,
NIA,
NIDCD,
ORWH,
NICHD,
NINR,
NINDS,
NIDCR
|
Aug 6, 2020 |
Sep 16, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). |
NOT-OD-20-159 |
NIH,
NLM
|
Aug 6, 2020 |
Aug 22, 2020
|
333 |
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative |
NOT-OD-20-144 |
NIH,
NIDCD
|
Jul 10, 2020 |
Aug 6, 2020
|
|
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
RFA-DK-20-021 |
NIDDK
|
Jul 10, 2020 |
Dec 17, 2020
|
R01 |
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-082 |
NCI
|
Jul 6, 2020 |
Aug 15, 2020
|
333 |
Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers |
NOT-CA-20-077 |
NCI
|
Jun 25, 2020 |
Jul 31, 2020
|
|
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) |
PAR-20-237 |
NIMHD,
NIDCD,
NIMH,
ODP,
NINR,
NIA,
SGMRO,
NIDDK,
NIEHS,
NICHD,
NCATS,
ORWH,
NIAAA,
NCCIH,
NIDA,
NEI,
NIDCR
|
Jun 17, 2020 |
Dec 2, 2020
|
R01 |
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need |
NOT-TR-20-029 |
NCATS
|
Jun 15, 2020 |
Nov 11, 2020
|
333 |
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-121 |
NIH,
NIDCR,
NICHD,
NCI,
NCATS,
NEI,
NHLBI,
NIAID,
NIAMS,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIAAA,
NIDA,
NIMHD,
ORWH,
OBSSR,
NLM,
SGMRO,
THRO,
NIA,
NCCIH,
ODP
|
Jun 12, 2020 |
Aug 8, 2020
|
333 |
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-120 |
NIH,
NIAID,
NIBIB,
NIDCR,
NIMHD,
NICHD,
NIAMS,
FIC,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIAAA,
NIA,
NIDCD,
NIDA,
ORWH,
OBSSR,
ODP,
NLM,
SGMRO,
THRO
|
Jun 12, 2020 |
Sep 9, 2020
|
333 |
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations |
NOT-OD-20-119 |
NIH,
NICHD,
FIC,
NCI,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAID,
NIAMS,
NIBIB,
NIDCR,
NIDDK,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINDS,
NINR,
NIA,
NIAAA,
NIDA,
NIMHD,
ORWH,
ODP,
NLM,
SGMRO,
THRO,
NIDCD,
OBSSR
|
Jun 12, 2020 |
Sep 9, 2020
|
333 |
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) |
RFA-OD-20-013 |
NIH,
NCI,
NIAMS,
NIA,
NICHD,
FIC,
NCATS,
NCCIH,
NEI,
NHLBI,
NIBIB,
NIDCR,
NIEHS,
NIGMS,
NHGRI,
NIMH,
NINR,
NIDCD,
NIDA,
NIMHD,
ORWH,
OBSSR,
NLM,
SGMRO,
THRO,
ODP
|
Jun 12, 2020 |
Aug 8, 2020
|
U24 |
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) |
RFA-CA-20-038 |
NCI,
NIAID
|
Jun 5, 2020 |
Jul 23, 2020
|
U54 |
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) |
RFA-CA-20-039 |
NCI,
NIAID
|
Jun 5, 2020 |
Jul 23, 2020
|
U01 |
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations |
NOT-MD-20-022 |
NIMHD,
ORWH,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NIEHS,
NIMH,
OBSSR,
ODP
|
Jun 5, 2020 |
Dec 30, 2020
|
333 |
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 |
NOT-MH-20-053 |
NIMH,
NCATS,
NCCIH,
NEI,
NHLBI,
NIAAA,
NICHD,
NIDA,
NIDCD,
NIDCR,
NIDDK,
NINR,
OBSSR,
ODP,
ORWH
|
Jun 5, 2020 |
Dec 30, 2020
|
333 |
Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) |
NOT-MH-20-058 |
NIMH,
NIAAA,
NIA,
NCCIH,
NIDCD,
NICHD,
NINR,
OBSSR,
ODP,
NIDCR,
NIDA,
NEI
|
Jun 4, 2020 |
Jun 26, 2020
|
|
Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) |
NOT-MD-20-023 |
NIMHD,
NIDCD,
OBSSR,
NIDA,
NINR,
ODP,
NCCIH,
NIMH,
NIDCR,
NIEHS,
NIA,
NICHD,
ORWH
|
Jun 3, 2020 |
Jun 17, 2020
|
|
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives |
NOT-OD-20-112 |
NIH
|
May 29, 2020 |
Jun 26, 2020
|
|
Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research |
NOT-OD-20-107 |
NIH
|
May 27, 2020 |
Jun 30, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) |
NOT-AT-20-012 |
NCCIH
|
May 26, 2020 |
Aug 18, 2020
|
333 |
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) |
RFA-RM-20-020 |
RMOD
|
May 21, 2020 |
Oct 1, 2020
|
R01 |
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) |
RFA-RM-20-021 |
RMOD
|
May 21, 2020 |
Sep 5, 2020
|
DP5 |
Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-051 |
NIAID
|
May 19, 2020 |
Sep 8, 2020
|
R03,R43/R44,R41/R42 |
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence |
NOT-CA-20-066 |
NCI
|
May 15, 2020 |
Jun 5, 2020
|
|
Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR |
NOT-DE-20-022 |
NIDCR,
ORWH
|
May 5, 2020 |
Nov 3, 2020
|
333 |
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network |
NOT-DE-20-023 |
NIDCR
|
May 1, 2020 |
Nov 3, 2020
|
X01 |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) |
PAR-20-177 |
NIAID
|
Apr 30, 2020 |
Aug 14, 2020
|
R21 |
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) |
PAR-20-178 |
NIAID
|
Apr 30, 2020 |
Aug 14, 2020
|
R01 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials |
NOT-HL-20-782 |
NHLBI
|
Apr 27, 2020 |
Oct 6, 2020
|
333 |
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) |
NOT-LM-20-011 |
NLM
|
Apr 27, 2020 |
Jun 17, 2020
|
R21 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-RM-20-015 |
RMOD
|
Apr 27, 2020 |
Jun 20, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs |
NOT-TR-20-028 |
NCATS
|
Apr 23, 2020 |
Nov 11, 2020
|
333 |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) |
NOT-LM-20-010 |
NLM
|
Apr 16, 2020 |
Jun 2, 2020
|
333 |
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-007 |
NIBIB
|
Apr 10, 2020 |
Aug 29, 2020
|
R01,R21,R03 |
Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 |
NOT-GM-20-027 |
NIGMS
|
Apr 10, 2020 |
May 6, 2020
|
333 |
NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) |
NOT-ES-20-017 |
NIEHS
|
Apr 10, 2020 |
Apr 25, 2020
|
333 |
Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-006 |
NIBIB
|
Apr 10, 2020 |
Sep 6, 2020
|
R41/R42,R43/R44 |
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) |
NOT-EB-20-008 |
NIBIB
|
Apr 10, 2020 |
Aug 29, 2020
|
333 |
Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 |
NOT-NS-20-046 |
NINDS
|
Apr 10, 2020 |
May 9, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission |
NOT-DK-20-020 |
NIDDK
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-043 |
NCI
|
Apr 9, 2020 |
Jun 26, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK |
NOT-DK-20-018 |
NIDDK
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) |
NOT-DC-20-004 |
NIDCD
|
Apr 9, 2020 |
Jun 2, 2020
|
333 |
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) |
NOT-AT-20-011 |
NCCIH,
NIA,
NIAAA,
ODP
|
Apr 9, 2020 |
Oct 7, 2020
|
333 |
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-CA-20-042 |
NCI
|
Apr 9, 2020 |
Jun 26, 2020
|
333 |
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus |
NOT-HG-20-030 |
NHGRI
|
Mar 31, 2020 |
May 16, 2020
|
333 |
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
NOT-TR-20-012 |
NCATS
|
Mar 27, 2020 |
Oct 17, 2020
|
UH2,U01,U34 |
RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) |
NOT-ES-20-014 |
NIEHS
|
Mar 27, 2020 |
Apr 25, 2020
|
333 |
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-034 |
NIAID
|
Mar 25, 2020 |
Jul 6, 2020
|
333 |
RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) |
NOT-HL-20-757 |
NHLBI
|
Mar 17, 2020 |
May 15, 2020
|
333 |
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) |
NOT-AI-20-030 |
NIAID,
NIGMS
|
Feb 6, 2020 |
Apr 8, 2020
|
333 |
|